Posted by Michael Wonder on 07 Jul 2022
PHARMAC keeps medical devices role despite failing to curb costs
8 July 2022 - The government is persisting with a way of buying hugely expensive medical devices that has been proven ineffective.
PHARMAC has failed to deliver many savings and has yet to set up a way to assess medical devices technologically, even the high-risk and high-cost ones, despite 10 years of trying.
PHARMAC's brief to get the best deal on drugs was expanded in 2012 to do the same for medical devices - everything from cheap tongue depressors to high-tech hip implants.
